BETAFERON

This brand name is authorized in Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug BETAFERON contains one active pharmaceutical ingredient (API):

1 Interferon beta-1b, recombinant UNII TTD90R31WZ - INTERFERON BETA-1B

Interferon beta-1b has been shown to possess both antiviral and immunoregulatory activity. The mechanisms by which interferon beta-1b exerts its actions in multiple sclerosis are not clearly understood. However, it is known that the biological response-modifying properties of interferon beta-1b are mediated through its interactions with specific cell receptors found on the surface of human cells. Read about Interferon beta-1b

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AB08	Interferon beta-1b	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8101J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912040011712
Country: EE	Ravimiamet	Identifier(s): 1071245, 1205457, 1397550, 1397561, 1461057, 1461068, 1662667
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 95003005, 95003005IP1
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 134546
Country: FR	Base de données publique des médicaments	Identifier(s): 64488861
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 367626, 45123
Country: HK	Department of Health Drug Office	Identifier(s): 47987
Country: IE	Health Products Regulatory Authority	Identifier(s): 88001, 89116
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6119
Country: JP	医薬品医療機器総合機構	Identifier(s): 6399416D1033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027712, 1027713, 1036694, 1036695, 1056536, 1056537, 1061960, 1061961, 1077761
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 83879, 90425
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7487
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100112530
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63878007
Country: SG	Health Sciences Authority	Identifier(s): 11228P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12853031H
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/34/0185